Search
for

    GlossaryClascoterone (Breezula)

    topical medication that blocks androgen receptors to treat hair loss

    Clascoterone is a topical medication used to treat acne and androgenetic alopecia (a common form of hair loss). It works by blocking androgen receptors in the skin, which helps reduce the effects of hormones like testosterone that can contribute to these conditions.

    Related Terms

    Learn

    2 / 2 results

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors
      [object Object]

    Research

    5 / 11 results

    Community Join

    5 / 203 results

      community Breezula phase 3 results said to be released next month

      in Product  25 upvotes 4 weeks ago
      Breezula's phase 3 results are expected soon, with discussions on the effectiveness of androgen receptor antagonists like spironolactone and the potential of GT20029. Users express skepticism about new treatments and discuss the complexities of male pattern baldness, often relying on finasteride despite its side effects.
      [object Object]

      community Breezula will hit the market in 2026, Cosmo Pharmaceuticals statement!

      in Product  52 upvotes 10 months ago
      Breezula, a hair loss treatment, is expected to cost around $100 a month and is anticipated to be released in 2026. The effectiveness of Breezula is debated, with some suggesting it loses effectiveness over time and others arguing it maintains hair compared to baseline.

      community Breezula hasn't even begun phase 3 trials yet. F*cking hell.

      in Treatment  44 upvotes 3 years ago
      The conversation is about the delay in Breezula's phase 3 trials and skepticism regarding its effectiveness compared to other treatments like RU58841 and Pyrilutamide. Some users prefer safety over effectiveness, while others express frustration with the slow progress and doubt Breezula will be a significant treatment for hair loss.